we injected 1% sodium tetradecyl sulfate into the lesions. After treatment, the lesions degenerated, and the results were aesthetically satisfying to the patients. The treatments were effective, within a short period of time after the injection and no lesion recurrence was observed one year postoperatively. We are providing the patient case reports and discussion about this treatment application.
I. Introduction
A vascular malformation is a congenital lesion that occurs frequently in the oral cavity, in the head, and in the neck, and vascular malformations are bluish, compressible, and nonpulsatile 1 . Because vascular malformations do not have clinically specific symptoms and do not resolve independently, they must be treated with laser therapy, embolization, electrocauterization, steroid administration, surgical removal, or sclerotherapy, depending on the type, location, and depth of the lesion and the patient's conditions [2] [3] [4] [5] . There are several agents that are used for sclerotherapy, and sodium tetradecyl sulfate is known to induce extra-vascular inflammation as well as thrombosis, resulting in ischemic necrosis of blood vessels 6 . Two patients visited the Department of Oral and Maxillofacial Surgery at Chosun University Dental Hospital (Gwangju, Korea) to be treated for intraoral vascular malformations, and buccal mucosa lesions) according to the manufacturer's instructions. Wet gauze was used to apply pressure about 5 minutes after the injection. A week later, another injection of 1% sodium tetradecyl sulfate was given in the same doses into the lesions in the lower lip and in the left buccal mucosa. When he revisited the hospital two months later, all of the lesions had disappeared. (Fig. 3) All of the patient's intraoral lesions satisfactorily degenerated two months later, and upon followup, the patient has not developed any specific complications for a full year after the treatment was finished. (Fig. 4) 
Case 2
A 45-year-old man visited the hospital mainly because of painless red swelling in the left buccal mucosa. (Fig. 5 ) He had experienced the condition for seven or eight years and was clinically diagnosed with venous malformation in the left buccal mucosa. On the day he visited the hospital, 1 mL of 1% sodium tetradecyl sulfate was directly injected into the lesion, according to the manufacturer's instructions. Two weeks later, he complained of mild pain at the treatment site;
The patient was diagnosed with multiple vein malformations and 2 mL of 1% sodium tetradecyl sulfate was directly injected into the lesions (1 mL on the tongue and 1 mL on multiple A B Fig. 1 . Multicentric venous malformations of the tongue (A) and oral mucosa (B) in a 57-year-old man before sclerotherapy. 
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however, the lesion became smaller and normal color was returning to the site. (Fig. 6 ) When he revisited the hospital two weeks later, the pain had subsided, the lesion had completely degenerated, and the site had regained normal color. (Fig. 7) The patient has maintained good conditions and has not experienced lesion recurrence for a year after the treatment was completed.
III. Discussion
Mulliken and Glowacki 7 note that vascular malformations are congenital and tend to become more visible over time, even if it they are not observed in early stages. These types of malformations can be classified into arterial, arteriovenous, venous, capillary, and lymphatic malformations, based on the blood vessel that is associated with the lesion. The male-to-female ratio of occurrence is 1 to 1, and the process A B 14 reported that sodium tetradecyl sulfate injected into vascular malformation lesions could induce allergic and anaphylactic reactions. An injection of 0.5 to 2 mL per dose in lesions is possible, and the minimum dose is recommended. In addition, an injection dose greater than 2 mL is not recommended in one lesion, but interval injections over 5 to 7 days are recommended, based on the manufacturer's instructions. In these cases, since the lesions were in the outer layer and were relatively small, sclerotherapy that applied 1% sodium tetradecyl sulfate injected directly into the lesions was used to minimize both the side effects of the agent and the surgical burden on the patient. A maximum of two injections of the sclerosant generated lesion degeneration and aesthetically satisfactory effects in both cases. The treatment was finished when no recurrence was found in either patient upon followup a year later. However, it is unreasonable to use sclerotherapy alone for large-sized vascular lesions in the deep layer. In such cases, it is possible to use sclerotherapy as supplementary therapy before a surgical procedure to preoperatively reduce the size of the lesions 13 .
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involves constant expansion of an abnormal blood vessel that is surrounded by squamous endothelial cells, with no cellular hyperplasia in the histological respect. Waner and Suen 8 grouped arterial and arteriovenous malformations into fast flow lesions and venous, capillary, and lymphatic malformations into slow flow lesions.
Clinically, the malformations are bluish, compressible, and non-pulsatile and they are primarily connected with various anatomical structures in outer and deep layers 1 . An intraoral lesion tends to be asymptomatic in many cases, but never disappears by itself and results in bleeding, pain, tissue necrosis, secondary infection, or aesthetic defects, if neglected 2, 4, 9 . An intraoral lesion can be treated with surgical removal, embolization, cryotherapy, steroid administration, laser therapy, sclerotherapy, or a combination of these techniques [3] [4] [5] . Since the treatment depends on the type, location, and size of lesions, it is essential to correctly examine the malformation. Doppler ultrasound is recommended for examination and can best be supplemented by computed tomography or by MRI 10 . Surgical removal is the most widely-used method to treat vascular malformations. However, the demand for less invasive treatments, which are useful especially in cases that involve important anatomical structures or small lesions, has resulted in the introduction of sclerotherapy 11 . The sclerosants used to treat the condition include ethanolamine oleate, ethibloc, bleomycin, and sodium tetradecyl sulfate 11, 12 . These agents commonly provide a stimulus to vascular endothelial intima, induce extra-vascular inflammatory reactions, and ultimately cause vascular fibrosis and occlusion.
Of these, ethanolamine oleate is known to be a sclerosant with the lowest recurrence rate, which is effective even against venous malformation lesions that are more than 5 cm in diameter. However, this agent should be injected with care because it can affect normal structures if it flows into neighboring normal tissues 1 . Johann et al. 13 injected 1.25% or 2.5% ethanolamine oleate into intraoral vascular malformation lesions in thirty patients at fifteen-day intervals. They found that more than 20 mm lesions disappeared with six injections on average, and less than 20 mm lesions disappeared with two injections, on average. They reported that seventeen patients complained of symptoms that included pain, edema, and flare for a maximum of 72 hours after the treatment, and, similarly, the patient in the second case of this study experienced mild pain after the treatment. Hassan et al. 11 injected a maximum of 15 mg bleomycin into intravascular lesions, three or four times on average and six times at maximum, in 69 patients and observed definite
